Features Akkermansia muciniphila, a key component of a balanced gut microbiome
Compounded semaglutide and tirzepatide are prepared by licensed 503A compounding pharmacies, which operate under pharmacy compounding regulations established by the FDA and state pharmacy boards
Food & Drug Administration, Current and Resolved Drug Shortages and Discontinuations Reported to FDA (2025).
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
And in the stomach, acid and digestive enzymes rapidly break down peptides like semaglutide unless they are specially formulated with absorption enhancers, as in the approved oral form of semaglutide
Interestingly, many other endogenous mediators, such as regulatory peptides not necessarily directly related to respiratory tract functioning, have been implicated in mediation of asthma related inflammatory process and airway hyperreactivity (AHR) [4,5]